On this episode of The Bio Report podcast Immuneering co-founder and CEO Ben Zeskind discusses the company’s evolution from its roots in bioinformatics, movement into drug development, and the proprietary platform’s technological processes. The Bio Report podcast is hosted by Daniel Levine of Levine Media Group. Listen to the full interview below:
